Comparing Low-Volume PENG Block With Dexamethasone to Standard-Volume PENG Block for Pain and Muscle Function After Hip Replacement Surgery
Led by Ain Shams University · Updated on 2026-10-16
60
Participants Needed
1
Research Sites
2 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are comparing two methods of the pericapsular nerve group PENG block to manage pain and preserve quadriceps muscle function after primary unilateral total hip arthroplasty performed under spinal anesthesia. This study evaluates whether a low-volume PENG block combined with dexamethasone differs from the standard-volume PENG block in the time until first rescue pain medication is needed and in the incidence and severity of quadriceps weakness. The trial focuses on patients aged 50 to 70 years with ASA physical status I or II.
Participants will be randomly assigned to receive either a standard 20 mL PENG block of bupivacaine 0.25% or a low-volume 10 mL PENG block consisting of 5 mL bupivacaine 0.5%, 4 mL saline, and 4 mg dexamethasone. Both groups will receive spinal anesthesia with heavy bupivacaine 0.5% and fentanyl. The PENG block is performed under ultrasound guidance by an expert anesthesiologist. All patients will receive intravenous paracetamol every 8 hours and rescue nalbuphine if pain scores reach 4 or higher.
Participants will be evaluated for pain at rest and during movement at 2, 6, 12, and 24 hours after surgery. Quadriceps strength will be assessed at 6, 12, and 24 hours compared to preoperative baseline using the Medical Research Council scale and ability to perform a straight leg raise. Researchers will also measure total opioid consumption and time to first walking within the first 24 hours. The primary outcome is the time from block completion to first rescue analgesia within 24 hours postoperatively.
CONDITIONS
Brief Title
Low-Volume Pericapsular Nerve Group (PENG) Block With Dexamethasone vs Standard-Volume PENG Block After Total Hip Arthroplasty
Research Team
M
Mohamed F Morsi, M.B., B.Ch., M.Sc.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Scheduled for elective primary unilateral total hip arthroplasty under spinal anesthesia.
No sex restriction.
You will not qualify if you...
Patient refusal to participate.
Physical status ASA III or higher.
Contraindications to spinal anesthesia such as blood clotting problems, infection at injection site, or high intracranial pressure.
Undergoing revision or bilateral total hip arthroplasty.
Known allergy or sensitivity to bupivacaine, dexamethasone, paracetamol, or nalbuphine.
Pre-existing neuromuscular diseases, lower-limb motor deficits, or neuropathic pain.
Uncontrolled diabetes with HbA1c above 8% or fasting blood glucose above 180 mg/dL, or any contraindication to corticosteroids.
Cognitive impairment preventing pain or motor assessments, or chronic opioid use.
Body mass index over 40 kg/m2 preventing adequate ultrasound imaging.
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - 24 hours postoperatively
Participants receive spinal anesthesia followed by an ultrasound-guided PENG block with either standard or low-volume local anesthetic with dexamethasone. Pain relief and muscle strength are monitored.
Assessments at 2, 6, 12, and 24 hours after surgery
Follow-up
Duration - 24 hours postoperatively
Researchers assess pain scores, quadriceps strength, opioid use, and time to first walking within the first 24 hours after surgery.
Monitoring during hospital stay following treatment
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Comparing Dexamethasone and Dexmedetomidine Added to 0.25% Bupivacaine for Ultrasound-Guided TAP Block to Improve Pain Relief After Laparotomy
Surgical Reconstruction Using Achilles Tendon Allograft Versus Physiotherapy for Gluteus Medius Insufficiency After Hip Replacement
Effectiveness of Aloe Vera Gel vs Paraffin-Based Tulle Dressings for Reducing Pain at Skin Graft Donor Sites in Adults Aged 18 to 60
Effectiveness of Different Doses of Liposomal Bupivacaine in Nerve Block for Pain Relief After Robotic Total Knee Replacement Surgery
Comparing Continuous Intravenous Ketamine Infusion and PCA Ketamine for Managing Acute Pain After Major Orthopedic Surgery
Comparing Postoperative Pain Relief Using Quadratus Lumborum and Transversalis Fascia Blocks in Elective Inguinal Hernia Surgery
Evaluating Surgeon-Administered Transversus Abdominis Plane Blocks for Pain Relief After Cesarean Section Surgery
Evaluating a Standardized Anesthetic Protocol for Pediatric Patients Undergoing Le Fort Osteotomy at Johns Hopkins Hospital to Improve Recovery and Reduce Pain
Study of Antibiotic-Impregnated Bone Graft to Lower Infection Risk After Hip Replacement Surgery
Evaluating Autonomic Neural Blockade to Reduce Pain and Nausea After Sleeve Gastrectomy or Gastric Bypass Surgery
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Perineural dexamethasone effectively prolongs anaesthesic block duration in total hip arthroplasty, reduces opioid consumption, and does not compromise motor function, nerve integrity, or glycaemic control.
Tomasz Reysner, Grzegorz Kowalski, Aleksander Mularski...
The efficacy of pericapsular nerve group block for postoperative analgesia in patients undergoing hip surgery: A systematic review and meta-analysis of randomized controlled trials.
Dose-response relationships of intravenous and perineural dexamethasone as adjuvants to peripheral nerve blocks: a systematic review and model-based network meta-analysis.
Paul J Zufferey, Robin Chaux, Pierre-Adrien Lachaud...
Ultrasound-Guided Pericapsular Nerve Group Block for Hip Surgery: A Randomized Controlled Trial Study Comparing Ropivacaine and Ropivacaine With Dexamethasone.